News Archives | Page 3 of 4 | React4Life

Partnership

November 16, 2021

React4life and Biosigma partners for the distribution of MIVO® in Italy

Oncology, immunotherapy, cells and MIVO®.

April 28, 2021

Oncology, immunotherapy, cells and MIVO®. The fundamentals of our new senior scientist Monica

MIVO and microfluidic

February 5, 2021

MIVO® and microfluidic chip in pharmaceutical analysis

The challenge of the cosmetics industry

November 18, 2020

The challenge of the cosmetics industry: discovering compounds that block pollutants in contact with the skin.

Reducing the time and cost of screening

October 16, 2020

Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.

intestinal permeability

August 27, 2020

MIVO® and intestinal permeability, a perfect combination to study the absorption mechanism and the biological effects of drugs and food compounds

To each his own therapy

August 24, 2020

To each his own therapy. Organoids, test in vitro and MIVO devices to test specific treatments suggested by our own cells

July 16, 2020

Covid19 and heart: an advanced in vitro research on infection mechanism

3D Human Cancer Models

June 20, 2020

3D Human Cancer Models with MIVO and Culturing 3D Tissues: we talk about it today at the Drug Discovery summit

The demand of anti-pollution

May 31, 2020

The demand of anti-pollution beauty products is growing in 2020

Absorption test

May 28, 2020

Our Absorption test is the innovative solution to the EU regulation 2017/745 relating to medical devices

How is the study on the evaluation

May 27, 2020

How is the study on the evaluation of alternative methods to animal testing going?